Curis Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.03

+0.12 (+13.11%)

As of Feb 8, 2:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +354.4% upside

Low Target $2.81

Average Target $4.68

High Target $5.27

Current Price $1.03

Current
$1.03

Target
$4.68

$2.81 $4.68 avg $5.27

Scenario Analysis

Bear Case

$2.81

172.8%

Low target

Base Case

$4.68

+354.4%

Avg target

Bull Case

$5.27

+411.7%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$4.14

-75.1% from high

52-Week Low

$1.86

+-44.6% from low

Target vs 52W High

$4.68

+13.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%